Activity of eosinophilic esophagitis can be measured by patient reported outcomes, and clinician-reported outcomes.
Over the last years efforts have been underway to develop and validate instruments to assess eosinophilic esophagitis activity in the different domains.
Dr Schoepfer and colleagues from Switzerland provide an overview of the current status of instruments that assess eosinophilic esophagitis activity in the different domains.
|Standardization will allow eosinophilic esophagitis researchers to define meaningful endpoints used in studies |
|Diseases of the Esophagus|
The team report that such instruments are urgently needed to standardize the language of eosinophilic esophagitis activity assessment and, in so doing, to facilitate communication among various stakeholders.
Dr Schoepfer's team concludes, "Such standardization will ultimately allow eosinophilic esophagitis researchers to define meaningful endpoints for use in clinical trials and observational studies, to compare the efficacy of different therapeutic modalities, and to develop algorithms in order to provide patients with the appropriate therapy."